Sophie Grigoriadis, MD, PhD
- 7Articles
- 97.2KReads
- 2013–2019Active
- 30Collaborators
- 1.5KCitations
About
Sophie Grigoriadis, MD, PhD, has published extensively on the treatment and outcomes of depression and anxiety during pregnancy, with a focus on maternal mental health and perinatal outcomes. Her work includes systematic reviews and meta-analyses examining the safety and effects of antidepressant and benzodiazepine use in pregnant women, as well as psychiatric hospitalizations related to schizophrenia during and after pregnancy. Grigoriadis has contributed to research on optimizing patient care for women with major depressive disorder (MDD) in the perinatal period.
Publications
Hospitalizations and Emergency Department Visits for Psychiatric Illness During and After Pregnancy Among Women With Schizophrenia
April 27, 2016
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
